Leishmaniasis is a vector-borne disease caused by different species of protozoan parasites
of the genus Leishmania. It is a major health problem yet neglected tropical diseases, with …

Visceral leishmaniasis, which is also known as Kala-Azar, is one of the most severely
neglected tropical diseases recognized by the World Health Organization (WHO). The threat …

The solid lipid nanoparticles (SLNs) usually consists of active drug molecules along with
solid lipids, surfactants, and/or co-surfactants. They possess some potential features such as …

Leishmaniasis is caused by protozoan Leishmania parasites that are transmitted through
female sandfly bites. The disease is predominantly endemic to the tropics and semi-tropics …

Introduction: The search for vaccines to prevent human leishmaniasis is an active field of
investigation aimed to prevent the devastating effects of this family of diseases on human …

Visceral leishmaniasis (VL) caused by Leishmania infantum is endemic in the
Mediterranean basin with most of the infected human patients remaining asymptomatic …

Currently, there are no commercially available human vaccines against leishmaniasis. In
rodents, cellular immunity to salivary proteins of sand fly vectors is associated to protection …

Leishmaniasis is a vector-borne infectious disease caused by multiple Leishmania (L.)
species with diverse clinical manifestations. There is currently no vaccine against any form …

Leishmaniasis (or the leishmaniases), classified as a neglected tropical parasitic disease, is
found in parts of the tropics, subtropics and southern Europe. Leishmania parasites are …

To ensure success in the development and manufacturing of nanomedicines requires forces
of an interdisciplinary team that combines medicine, engineering, chemistry, biology …